Case Study: Novo Nordisk transforms digital patient engagement with Valtech

Novo Nordisk launches Diabetes What’s Next with Valtech, reaching 9,000 visitors in the first months

Valtech partnered with Novo Nordisk, a global healthcare company, to address challenges in digital patient engagement. The key challenges were engaging an increasingly digitally savvy patient population and improving adherence to complex diabetes treatment regimens, which is influenced by a range of biomedical, psychological, and cultural factors.

Valtech implemented an innovative digital portal called Diabetes What’s Next, built as an MVP using Adobe Analytics and Adobe Target to enable automated personalization. This solution marked a true transformation in Novo Nordisk's digital approach, supporting a long-term omnichannel vision. The portal attracted over 9,000 visitors in its first months and is being rolled out globally in multiple languages, representing a significant organizational shift towards more personalized, patient-centric digital engagement.

Novo Nordisk